Every material Form 8-K Healthcare Realty Trust has filed with the SEC since February 19, 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Healthcare Realty reported third quarter 2026 results on October 29, 2026, with Normalized FFO of $0.42 per diluted share, up from $0.41 a year earlier, and a GAAP net loss of $(0.05) per share, narrower than the $(0.17) loss in the prior-year quarter. The company raised its full-year 2026 Normalized FFO guidance to $1.65-$1.67 per share from $1.62-$1.66 and raised its Same Store Cash NOI growth guidance to 5.00%-5.25%. Third quarter revenue fell to $286.6 million from $297.8 million a year earlier.
Q3 2026 Normalized FFO of $0.42 per diluted share, versus $0.41 in Q3 2025; NAREIT FFO of $0.38 versus $0.34
Q3 2026 GAAP net loss attributable to common stockholders of $15.8 million, or $(0.05) per share, versus $57.7 million, or $(0.17) per share, a year earlier
Full-year 2026 Normalized FFO guidance raised to $1.65-$1.67 per share from $1.62-$1.66 in July
Quarterly common dividend of $0.24 per share, payable November 20, 2026, to holders of record on November 10, 2026
Healthcare Realty reported second quarter 2026 total revenues of $281.8 million, down from $297.5 million a year earlier, and a GAAP net loss of $43.5 million, or $(0.13) per share, narrowed from $(0.45) a year earlier. Normalized FFO was $0.41 per share, flat with the prior-year quarter, and the company raised its full-year Normalized FFO guidance, but it lowered its full-year GAAP earnings per share guidance.
Q2 2026 total revenues were $281.8 million, versus $297.5 million in Q2 2025; GAAP net loss attributable to common stockholders was $43.5 million, or $(0.13) per share, versus $(0.45) per share a year earlier.
Normalized FFO was $0.41 per share, unchanged from Q2 2025; NAREIT FFO was $0.36 per share, up from $0.34.
2026 Normalized FFO guidance rose to $1.62 to $1.66 per share from $1.59 to $1.65; earnings per share guidance moved to $(0.15) to $(0.11) from $(0.05) to $0.05.
The board approved a $0.24 per share dividend payable August 26, 2026, to holders of record on August 11, 2026.
Healthcare Realty Trust and its operating partnership entered into a $400.0 million senior unsecured delayed draw term loan facility with Wells Fargo Bank as administrative agent, dated May 15, 2026. No borrowings were outstanding at closing, and the company can draw in up to three additional draws until the first anniversary of the closing date. The filing gives shareholders a committed source of borrowing with a scheduled maturity of May 15, 2029, and an accordion option for up to $100.0 million more.
Facility size: $400.0 million senior unsecured delayed draw term loan, with an accordion feature for up to an additional $100.0 million
Scheduled maturity: May 15, 2029; no borrowings outstanding as of the closing date
Agreement includes customary financial covenants, including leverage and coverage ratio requirements
Healthcare Realty Holdings, L.P., a subsidiary of Healthcare Realty Trust, issued $700 million of 3.00% exchangeable senior notes on May 7, 2026, including $100 million from the initial purchasers' full exercise of their option. The company fully and unconditionally guaranteed the notes, which are senior and unsecured, so the debt adds to the company's obligations for shareholders to consider.
Total principal of $700 million, including $100 million from the full exercise of the initial purchasers' option; notes mature January 15, 2032
Interest of 3.00% per year, paid semi-annually on January 15 and July 15, starting January 15, 2027
Initial exchange price of approximately $23.01 per share, equal to 43.4660 shares per $1,000 principal; the issuer may settle exchanges in cash or in cash and common stock
Company agreed to file a resale registration statement, with an effectiveness deadline of 180 days after the notes were first issued
Healthcare Realty Trust reported first quarter 2026 results on April 30, 2026. Normalized FFO was $0.41 per diluted share, up from $0.39 a year earlier, and the GAAP net loss narrowed to $56 thousand, or $(0.00) per share, from $44.9 million, or $(0.13) per share. Total revenues fell to $279.0 million from $299.0 million, and the company raised its 2026 Normalized FFO guidance to $1.59 to $1.65 per share.
Normalized FFO of $0.41 per diluted share, versus $0.39 in the first quarter of 2025; NAREIT FFO was $0.35 per share in both periods
GAAP net loss of $56 thousand, or $(0.00) per share, versus a net loss of $44.9 million, or $(0.13) per share, a year earlier
Total revenues of $279.0 million, versus $299.0 million in the first quarter of 2025
2026 Normalized FFO guidance raised to $1.59 to $1.65 per share from $1.58 to $1.64; quarterly dividend of $0.24 per share payable May 22, 2026
Healthcare Realty reported fourth quarter 2025 GAAP net income of $14.4 million, or $0.04 per share, compared with a net loss of $106.8 million a year earlier, and NAREIT FFO rose to $0.36 per share from $0.30. The company also issued 2026 guidance calling for Normalized FFO of $1.58 to $1.64 per share, roughly flat with $1.61 in 2025, and a $0.24 quarterly dividend.
Q4 2025 GAAP net income was $14.4 million ($0.04 per share) versus a net loss of $106.8 million ($0.31 per share) in Q4 2024.
Q4 2025 NAREIT FFO was $0.36 per share versus $0.30; Normalized FFO was $0.40 per share, unchanged from the prior year.
2026 guidance: Normalized FFO of $1.58 to $1.64 per share (2025: $1.61) and NAREIT FFO of $1.44 to $1.50 (2025: $1.38).
Dividend of $0.24 per share payable March 11, 2026, to holders of record on February 24, 2026; new commercial paper program of up to $600 million.
Healthcare Realty Trust appointed Daniel Gabbay, a former RBC Capital Markets managing director covering healthcare REITs, as executive vice president and chief financial officer effective January 12, 2026. CFO Austen Helfrich is leaving the same day, and the company expects to record a charge of approximately $5 million for the quarter ending March 31, 2026, related to his separation. The company said there is no change to its previously issued 2025 Normalized FFO guidance.
Daniel Gabbay becomes EVP and CFO effective January 12, 2026; he previously served as a managing director at RBC Capital Markets and Barclays.
Austen Helfrich, CFO since October 2024, departs effective January 12, 2026, under the termination other than for cause provisions of his employment agreement.
Gabbay's employment terms include a $500,000 base salary, a $625,000 target annual cash incentive, $1,375,000 in 2026 target equity awards, a $2,750,000 make-whole restricted stock award and $300,000 in relocation benefits.
The company expects a charge of approximately $5 million for the quarter ended March 31, 2026, tied to Helfrich's separation.
Healthcare Realty Trust entered into equity distribution agreements with 16 sales agents for an offering of Class A common stock of up to $1 billion, plus forward sale arrangements with 15 forward purchasers. The company has no obligation to sell any shares and may suspend the program at any time, and it says net proceeds would fund general corporate purposes, including healthcare facility acquisitions and development.
Equity Offering Program covers Class A common shares with an aggregate offering price of up to $1,000,000,000
Sales agents may receive up to 2.00% of gross proceeds from shares they sell
Shares will be issued under a Form S-3ASR registration statement, with a prospectus supplement dated December 17, 2025
Healthcare Realty reported third-quarter 2025 Normalized FFO of $0.41 per share, up from $0.39 a year earlier, and a GAAP net loss of $0.17 per share, narrower than the $0.26 loss in the prior-year quarter. The company raised its 2025 Normalized FFO per share guidance to $1.59-$1.61 and same store cash NOI growth guidance to 4.00%-4.75%, while third-quarter revenue of $297.8 million was below the $315.4 million reported a year earlier.
Normalized FFO per share was $0.41 in Q3 2025 versus $0.39 in Q3 2024; NAREIT FFO was $0.34 versus $0.21.
GAAP net loss attributable to common stockholders was $57.7 million ($0.17 per share) versus $93.0 million ($0.26 per share) a year earlier.
Total revenues were $297.8 million versus $315.4 million in Q3 2024.
2025 guidance: Normalized FFO per share raised to $1.59-$1.61 from $1.57-$1.61; same store cash NOI growth raised to 4.00%-4.75% from 3.25%-4.00%. The board approved a $0.24 per share dividend payable November 21, 2025.
Healthcare Realty reported a second-quarter GAAP net loss of $0.45 per share, wider than the $0.39 loss a year earlier, while normalized FFO rose to $0.41 per share from $0.38 and the company raised its 2025 normalized FFO guidance by one cent at the midpoint. The board also cut the common dividend 23% to $0.24 per share, which the company said reduces the FAD payout ratio to approximately 80%. New CEO Peter Scott, who joined April 15, is leading a strategic plan and platform restructuring.
GAAP net loss attributable to common stockholders was $157.9 million, or $(0.45) per share, versus $143.8 million, or $(0.39) per share, in the second quarter of 2024
Normalized FFO was $0.41 per share versus $0.38 a year earlier; 2025 normalized FFO guidance rose to $1.57 to $1.61 from $1.56 to $1.60
Quarterly common dividend of $0.24 per share, payable August 28, 2025, to holders of record on August 14, 2025
Peter Scott joined as President and CEO on April 15, 2025; the board was reduced from 12 to 7 members
Healthcare Realty Trust and its operating partnership entered a new credit agreement dated July 25, 2025, replacing the existing facility with a $1.5 billion unsecured revolver and five unsecured term loan tranches totaling $1.115 billion. The revolver's maturity was extended from October 31, 2025 to July 25, 2029, which pushes out near-term refinancing needs for shareholders.
Revolver maturity extended from October 31, 2025 to July 25, 2029, with two six-month extension options
Five term loan tranches totaling $1.115 billion, with maturities ranging from October 31, 2025 to January 20, 2028
Current revolver margin is 0.85% per annum over the applicable benchmark, with a range of 0.725% to 1.40% based on credit ratings
Wells Fargo Bank, National Association serves as administrative agent
Five Healthcare Realty directors retired from the Board effective June 18, 2025, and the Board immediately reduced its size from 12 to seven members. The company said the change aligns the Board's size with other REIT companies and reflects its governance practices, and the retiring directors reported no disagreement with the company.
Retiring directors: Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez, effective June 18, 2025
Board size reduced from 12 to seven members immediately
Remaining directors include independent chairman Thomas Bohjalian, President and CEO Peter Scott, David Henry, Jay Leupp, Constance Moore, Glenn Rufrano and Donald Wood
The filing states no executive officer is aware of, and no retiring director has informed the company of, any disagreement with the company
Healthcare Realty reported a first-quarter 2025 net loss attributable to common stockholders of $44.9 million, or $0.13 per diluted share, compared with a $106.8 million loss ($0.31 per share) in the fourth quarter of 2024. The company reaffirmed its 2025 guidance, including normalized FFO of $1.56 to $1.60 per share, and said Peter A. Scott becomes President and CEO on April 15, 2025.
Q1 2025 net loss attributable to common stockholders was $44.9 million, or $0.13 per diluted share, versus a $310.8 million loss ($0.82 per share) in Q1 2024
Normalized FFO was $0.39 per share in Q1 2025, versus $0.40 in Q4 2024 and $0.39 in Q1 2024
Peter A. Scott appointed President and CEO effective April 15, 2025; Connie Moore served as interim CEO from November 2024 until April 14, 2025
Quarterly dividend of $0.31 per share payable May 23, 2025, to holders of record on May 12, 2025
Healthcare Realty Trust's board appointed Peter A. Scott, formerly chief financial officer of Healthpeak Properties, as president and chief executive officer effective April 15, 2025. Interim CEO Connie Moore is leaving that role but will remain on the board and in a transition role for up to 60 days.
Scott's employment agreement sets a base salary of $750,000 and a 2025 annual cash incentive target of 180% of base salary, or $1,350,000.
For 2025, Scott's equity awards have a target value of $3,900,000, plus a one-time restricted stock award with a grant date value of $5,750,000 that vests over four years.
Scott has served as chief financial officer of Healthpeak Properties since February 2017 and is expected to join the board after the 2025 annual meeting.
Moore will receive a monthly salary of $90,000 during a transition role of up to 60 days.
Healthcare Realty Trust reported a fourth-quarter 2024 net loss attributable to common stockholders of $106.8 million, or $(0.31) per diluted share, compared with a $40.5 million loss a year earlier, while normalized FFO per share rose to $0.40 from $0.39. The company also named Connie Moore interim President and CEO and guided to a 2025 loss per share of $(0.28) to $(0.20), which matters to shareholders because it signals continued reported losses alongside a leadership transition.
Fourth-quarter total revenues were $309.8 million, down from $330.4 million a year earlier.
Normalized FFO per share was $0.40 for the quarter, at the high end of prior guidance and up 2.5% year over year.
2025 guidance: earnings per share of $(0.28) to $(0.20) and normalized FFO per share of $1.56 to $1.60.
Connie Moore was appointed interim President and CEO, and the board is searching for a permanent CEO; the quarterly dividend is $0.31 per share, payable March 19, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Healthcare Realty Trust filing is on SEC EDGAR ↗. 8-K briefs of other companies →